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Suicidality in Body Dysmorphic Disorder (BDD): A systematic review with meta-analysis. 
 
Body Dysmorphic Disorder (BDD) is a serious, incapacitating mental health condition 
characterized by a series of symptoms related to body image concerns, such as recurrent 
intrusive thoughts about perceived deformations or flaws in physical appearance (American 
Psychiatric Association, 2013). The prevalence of BDD is estimated to be about 2% in the 
general population (Buhlmann et al., 2010; Koran, Abujaoude, Large, Serpe, 2008), whereas 
in people seeking cosmetic surgery a BDD rate of 15.6% have been reported (Buhlmann et 
al., 2010). Although more common than other severe mental health conditions, such as 
schizophrenia and anorexia nervosa that range in prevalence from 0.5 to 1% in the general 
population (Hoek & Hoeken, 2003; Saha, Chant, Welham, & McGrath, 2005), BDD remains 
often unrecognized in clinical practice and its association with other serious mental health 
adversities, including suicidal ideation and suicide attempts has received scant research 
attention (Veale & Bewley, 2015). In this study the term suicidality was used to refer to 
suicidal ideation, plans and attempts and suicide deaths. It should be noted that in psychiatric 
inpatient settings, BDD is rarely identified unless a structured diagnostic interview is used 
(Grant, Kim, & Crow, 2001; Conroy, Menard, Fleming-Ives, Modha, Cerullo, & Phillips, 
2008; Veale, Akyuz, & Hodsoll, 2015). This has the consequence of under-estimating the 
number of patients with BDD, who are usually misdiagnosed as having depression, as well as 
the rates of suicide risk in people with BDD. 
BDD is classified under the category of obsessive-compulsive and related disorders in 
DSM-5, whereas in previous versions of DSM it was included in the category of somatoform 
disorders (APA, 2000, 2013). This shift in the conceptualization of BDD is consistent with 
the scientific literature showing that BDD and Obsessive Compulsive Disorder (OCD) are 
distinct, but closely related, and often comorbid, mental illnesses (Frare, Perugi, Ruffolo, & 
Toni, 2004; Phillips, Pinto, Menard, Eisen, Mancebo, & Rasmussen, 2007). A recent 
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systematic review and meta-analysis confirmed that there is a strong relationship between 
OCD and suicidality (Angelakis, Gooding, Tarrier, & Panagioti, 2015). Considering, 
therefore, the commonalities between BBD and OCD, which are accompanied by similar 
levels of functional impairment, we anticipated that suicidality also is manifest in people 
experiencing BDD. Consistent with this view, a number of studies have shown that patients 
with BDD are at particularly high risk of experiencing suicidality (e.g., Phillips, 2007; Philips, 
Coles, Menard, Yen, Fay, & Weisberg, 2005). For example, prevalence estimates of suicide 
attempts in people with BDD has been reported as 7.2% (Rief, Buhlmann, Wilhelm, 
Borkenhagen, & Brähler, 2006). The prevalence of such attempts in the general population 
has been documented as 2.7% world-wide (Nock et al., 2008), and in those with anxiety 
disorders and schizophrenia spectrum disorders as 3.4% and 10.9% respectively (Barak, 
Baruch, Achiron, & Aizenberg, 2008; Nepon, Belik, Bolton, & Sareen, 2010). 
Despite people with BDD being at high risk of engaging in suicide attempts, 
understanding the links between the severity and type of BDD symptoms and the 
development and maintenance of suicidality is under-researched in the extant literature. BDD 
is accompanied by high levels of psychological distress, hopelessness, and feelings of 
embarrassment, shame, or discomfort related to appearance and body image (Phillips, 2000; 
Phillips, McElroy, Keck Jr., Pope Jr., & Hudson, 1993; Veale, Gournay, Dryden, Boocock, 
Shah, & Willson, 1996). As a consequence, people with BDD often feel socially anxious, and 
withdraw from, or avoid, social interactions (Hollander & Abronowitz, 1999; Veale & 
Roberts, 2014). Empirically based contemporary models of suicidality indicate that such 
negative feelings, experiences, and perceptions, especially when linked with social isolation, 
are risk factors for the triggering, and maintenance, of suicidal thoughts, behaviors, and acts 
(Johnson, Gooding, & Tarrier, 2008; O'Connor & Nock, 2014; Tarrier et al., 2013; Williams, 
1997). Comorbid depressive symptoms also are common features of BDD (Phillips, Didie, & 
Menard, 2007) and may amplify relationships between the range of negative perceptions 
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associated with having BDD, resultant social isolation, and suicidality. To date, only one 
study (Witte, Didie, Menard, & Phillips 2012) attempted to investigate pathways to suicidality 
in people with BDD following a theoretical framework as postulated by the interpersonal-
psychological theory of suicide (Joiner, 2005; Van Orden et al., 2010). Among the key 
variables that predicted suicide attempts in BDD patients as supported by the study’s data 
were a diagnosis of PTSD, lifetime work impairment owning to BDD and lifetime BDD-
related restrictive food intake. Major depressive disorder together with lifetime work 
impairment were found to be among the critical variables that predicted suicidal ideation in 
BDD.  
In the absence of a systematic review, however, it is difficult to ascertain the levels of, 
and the mechanisms underlying suicidality in those experiencing BDD. Therefore, we decided 
to undertake a systematic review and meta-analysis with the following three core objectives: 
i. To systematically synthesize and quantify any association between BBD 
and suicidality.  
ii. To examine the underlying mechanisms of suicidality in BDD, which are 
likely to include specific features of BDD (e.g., severity, specific symptoms 
or sub-types), psychiatric comorbidities (e.g., depression, OCD) and other 
clinical, psychological or demographic factors. 
iii. To examine whether the co-presentation of OCD and BDD further escalates 
the risk for suicidality over and above the effects of OCD and BDD alone. 
2. Methods 
 This systematic review and meta-analysis was performed and presented in line with 
the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
statement (Moher, Liberati, Tetzlaff, & Altman, 2009).   
2.1. Eligibility criteria 
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 The identified studies had to meet three criteria to be included in the review: 
a) applied a quantitative research design (e.g., cross-sectional, prospective), 
b) investigated the relationship between suicidality and a diagnosis of BDD, or 
explored any factors that contributed to this relationship, 
c) was written in English and published in a peer-reviewed journal. 
Since this is the first systematic review in the field, we decided to adopt an 
inclusive approach and not to add any participant age limit. However, we anticipated 
that the vast majority of the eligible studies would recruit adults. Case studies, 
qualitative studies and non-empirical studies and reviews were excluded from this 
systematic review.  
2.2. Search strategy and data sources 
Five electronic bibliographic databases were searched which were Medline, 
PsychInfo, Embase, Web of Science, and CINAHL. We also identified eligible studies by 
checking the reference lists of the identified studies. Searches were conducted from inception 
to June 2015. Our search strategy included both text words and MeSH terms (Medical 
Subjective Headings) and combined two key blocks of key-terms: suicide (suicid* OR 
self*harm
1
) and BDD (body dysmorhic disorder OR BDD).  
2.3. Study selection 
Co-authors IA and MP independently screened the titles and abstracts of the research 
papers that were initially identified. The full text of the studies, which met the eligibility 
criteria, were accessed and screened again and independently by the two reviewers. Inter-rater 
reliability was high, kappa = 0.96. Disagreements were resolved through discussions.  
                                                 
1
 The focus of this review was on suicidality. Self-harm was included in the search terms to maximize the 
sensitivity of the searches. Although some studies might refer to self-harm, they actually include validated 
measures of suicidal thoughts and behaviors.  
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2.4. Data extraction 
An electronic data extraction form was developed and initially piloted with five 
randomly selected studies. Descriptive and quantitative data were extracted independently by 
two co-authors (IA and MP). Descriptive information included participant characteristics (i.e., 
age, gender, diagnoses), study characteristics (i.e., country, design, method of recruitment), 
BDD outcomes (i.e., screening/diagnostic tools for BDD), suicidality outcomes (i.e., 
screening tools for suicidality), and mode of suicidality (i.e., suicidal ideation, suicide 
attempts, plans, suicide deaths). Data were also extracted pertaining to the association 
between BDD and suicidality and the factors that underlie the BDD-suicide relationship. Co-
authors IA and MP carried out data extraction independently. The inter-rater reliability was 
high (kappa = 0.93) and based on the 655 data points examined.    
2.5. Appraisal of methodological quality  
The appraisal of the methodological quality of the studies was performed using six 
criteria adapted from the Centre for Reviews and Dissemination guidance for undertaking 
reviews in health care (CRD, 2009) and the Quality Assessment Tool for Quantitative Studies 
(Thomas, Ciliska, Dobbins, & Micucci, 2004). These criteria were: i) research design (cross 
sectional = 0, prospective/experimental = 1), ii) baseline participants’ response rate (>70% or 
not reported = 0, <70% = 1), iii) follow-up participants’ response rate (>70% or not reported 
= 0, <70% = 1), iv) measure of BDD (self-report scale/not reported = 0, structured/semi-
structured clinical interview = 1), v) measure for suicidality (not reported/other = 0, 
structured/semi-structured clinical interview/self-report scale = 1), and vi) control for 
confounding/other factors in the analysis (no controlled/not reported = 0, controlled = 1).  
2.6. Data analysis 
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The results of the individual studies measuring the relationship between 
suicidality and BDD were pooled using meta-analytic analysis techniques. Odds ratios 
(ORs) and associated Confidence Intervals (CI) for the outcome measures of these 
studies were calculated using STATA 12.1 (Stata, 2011).  ORs were the preferred 
pooled effect size because the vast majority of studies reported categorical outcomes, 
such as numbers/proportions of participants with or without BDD who evidenced 
suicidal ideation and attempts. Only one study reported a continuous outcome (mean 
number of suicide attempts in participants with BDD and without BDD) (Grant, Kim, 
& Crow, 2001), which was converted to OR based on the commonly used formula 
suggested by Borenstein, Hedges, Higgins, & Rothstein (2005). The pooled ORs in 
addition to the forest plots were computed using the meta-an command in STATA 
(Kontopantelis & Reeves, 2010). We only performed one subgroup analysis to 
examine whether the results of the association between BDD and suicidality varied 
across different types studies (studies based on clinical populations and large 
community surveys) and one sensitivity analysis to examine whether the results of the 
main analysis pertained when only studies with sound methodological properties were 
retained. All analyses were conducted using a random effects model because of 
anticipated heterogeneity. Heterogeneity was assessed using the I
2
 statistic (Higgins, 
Thompson, Deeks, Altman, 2003).  We also examined whether publication bias was 
present by inspecting the funnel plot and examining the significance of the Egger’s 
test (Egger, Smith, Schneider, Minder, 1997).  
Only a small proportion of studies examined the potential mechanisms 
underlying suicidality in BDD. All the available quantitative data addressing 
mechanisms of suicidality in BDD were converted to ORs to facilitate comparability, 
but meta-analysis was only used when pooling the data was appropriate. Instead, a 
narrative synthesis of the results was performed when data could not be pooled.  
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3. Results 
The search strategy yielded 325 articles. Of these, 51 were relevant for full-text 
screening. As shown in the flowchart (Fig. 1), 37 studies were eligible to be included in the 
review, but 18 were based on the same sample of participants (see Appendix 1). Among these 
18 studies, only one study (which provided the most complete data) was entered in the meta-
analysis. Therefore, this review comprised 20 independent studies. 
3.1. Descriptive characteristics of the studies 
Table 1 presents the characteristics of the 20 studies that were included in the review. 
Of these, ten were conducted in the US (50%), eight in Europe (40%) and two in Brazil 
(10%). All studies included participants of both sexes, but the majority of studies included a 
higher proportion of women. The mean age of the participants was 38 (SD = 10.96) with a 
range of 26.6 to 51 years. Two studies were conducted with children and adolescents with a 
mean age of 14.85 years (SD = 0.07). 
 As shown in Table 1, with the exception of two studies (which were based on 
either DSM-III-R or DSM-V), a BDD diagnosis and the assessment of the severity of 
BDD symptoms was based on DSM-IV criteria. A wide range of diagnostic tools for 
BDD was employed by different studies. Fifteen studies employed clinical interviews 
to assign a diagnosis of BDD, whereas five studies used validated self-report 
questionnaires. The most common assessment measures were the structured clinical 
interview for DSM-IV (SCID; First, Spitzer, Gibbon, & Williams, 2002) and the Body 
Dysmorphic Disorder Questionnaire (BDD-Q; Phillips, 1998).  
Seven studies provided data for suicidal ideation and suicide attempts, four 
studies measured suicidal ideation alone and two studies focused on suicide attempts 
alone. One study reported an aggregated score of suicidality. Suicidality was 
predominately determined using questions within the context of clinical interviews (n 
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= 7) and self-report questionnaires (n = 7). However, only three studies used validated 
questionnaires specifically designed to measure suicidality. Moreover, six studies 
failed to specify the measure used to assess suicidality. Only one study examined the 
link between BDD and suicide deaths.   
3.2. Rates of suicidality in BDD      
The rates of suicidal ideation in individuals with BDD ranged from 17% to 77.2% (weighted 
pooled rate = 0.53, 95% CI = 0.39 to 0.66), whereas the rates of suicide attempts ranged from 
2.6% to 62.5% (weighted pooled rate = 0.24, 95% CI = 0.16 to 0.35) (see Table 1). Six 
studies also examined the rates of suicidal ideation and suicide attempts attributed exclusively 
to BDD. BDD-induced suicidal ideation ranged from 19.1% to 69.7% (weighted pooled rate = 
0.52, 95% CI = 0.36 to 0.67) and BDD-induced suicide attempts ranged from 1.5% to 22.2% 
(weighted mean rate = 0.12, 95% CI = 0.07 to 0.21). The high variability in the reported rates 
of suicidal ideation and attempts is probably due to large variations across studies including 
differences in sample sizes, measures used to assess suicidality, and participant recruitment 
strategies/settings. Finally, information about suicide deaths was scarce. Only one study 
reported that two participants died by suicide from a sample of 185 participants with BBD 
(Phillips & Menard, 2006). 
3.3. Meta-analysis of the relationship between BDD and suicidality  
Fourteen studies provided data concerning the link between BDD and suicidality that 
were also amenable for meta-analysis. The remaining six studies focused on examining 
potential mechanisms underlying suicidality in BDD, or they did not provide sufficient 
information to allow computation of an effect size regarding the link between suicidality and 
BDD. None of the studies included amenable data with respect to the association between 
BDD and suicide deaths. Only data on suicide attempts were entered in the main analysis for 
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studies reporting data for both suicidal ideation and suicide attempts because the latter is more 
proximal to suicide deaths.   
3.3.1. Main analyses 
The pooled effect size across 14 relevant comparisons was statistically significant and 
positive, but high heterogeneity was present (OR = 3.35, 95% CI = 2.23 to 4.47, I
2 
= 69.5%, p 
< 0.001, see Fig. 2). These results indicate that individuals with BDD were four times more 
likely to exhibit elevated rates of suicidality compared to individuals without BDD (including 
healthy controls and individuals diagnosed with eating disorders, OCD or any other anxiety 
disorder). Across these 14 comparisons, only one reported ORs lower than 1 indicating that 
levels of suicidality were lower in individuals with BDD compared to the control group, but 
this effect was statistically non-significant.  
When examining suicidal ideation and suicide attempts in those with and without 
BDD (e.g., healthy controls, individuals diagnosed with eating disorders, OCD or any other 
anxiety disorder), those with BDD were four times more likely to have experienced suicidal 
ideation (pooled OR = 3.87, 95% CI = 2.32 to 5.32, I
2
 = 68.6%, p < 0.01, see Fig. 3) and  2.6 
times more likely to have made suicide attempts (pooled OR = 2.57, 95% CI = 1.44 to 3.69, I
2
 
= 65.4 %, p < 0.01, see Fig. 3). However, the heterogeneity was high in studies examining 
both suicidal ideation and suicide attempts analyses.   
3.3.2. Subgroup analysis 
This analysis focused on the link between BDD and suicidality across studies based on 
clinical populations and large community surveys based on non-clinical populations. Across 
studies based on clinical populations, those with BDD were over 2 times more likely to have 
experienced suicidality compared to those without BDD (e.g. typically psychiatric patients 
diagnosed with a range of other diagnoses in addition to BDD such as eating disorders, OCD 
or any other anxiety disorders) (pooled OR = 2.44, 95% CI = 1.37 to 3.51, I
2
 = 58.9%, p < 
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0.01; Fig. 4). Across community surveys, those with BDD were almost 6 times more likely to 
have experienced suicidality compared to those without BDD (mostly healthy controls) 
(pooled OR = 5.70, 95% CI = 2.49 to 8.91, I
2
 = 71.4 %, p < 0.05; Fig. 4).  
3.3.3. Sensitivity analysis  
 The methodological quality of the studies was medium to high (see Table 2). Of the 14 
studies analyzed, seven met three or four of the quality criteria. The pooled effect size of these 
seven studies (pooled OR = 3.35, 95% CI = 2.26 to 4.43, I
2
 = 90.3%, p < 0.001) was similar 
to the pooled effect size found in the main analysis of all 14 studies indicating that these 
results were not influenced by the methodological quality ratings. 
3.3.4. Publication bias 
No funnel plot asymmetry was observed suggesting that publication bias was not a 
problem in the current review. Consistent with this, the Egger test was non-significant for 
studies examining the association between BDD and suicidality (regression intercept = -0.58, 
SE = 1.78, p = 0.312 see Fig. 5). 
3.4. Mechanisms of suicidality in BDD 
In this section we outline factors, which are likely to act as mechanisms underlying 
suicidality in BDD, mainly narratively but where possible using meta-analysis.  
3.4.1. BDD-specific mechanisms 
 There was some evidence that BDD specific factors contributed to suicidality in BDD 
patients. The study by Phillips et al. (2005) demonstrated that BDD was the primary reason 
for suicidal ideation and suicide attempts across 70% of those diagnosed with BDD who 
reported suicidal ideation and across 50% who had previously made suicide attempts. Most 
importantly, individuals with BDD were highly likely to experience suicidal ideation (mean 
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rate of 46%) and suicide attempts (mean rate of 18%) attributed exclusively to BDD 
symptoms, such as, body image concerns. 
Consistent with this, the pooled ORs showed that those with BDD were at a 
disproportionally higher risk for both suicidal ideation (pooled OR = 5.11, 95% CI = 3.48 to 
6.74, I
2
 = 93.1%, p < 0.001) and suicide attempts (pooled OR = 6.24, 95% CI = 2.35 to 10.12, 
I
2
 = 90.0%, p < 0.001) induced by body image concerns compared to those without a BDD 
diagnosis (Buhlmann et al., 2010; Phillips, 1998; Rief et al., 2006).  
Certain characteristics of BDD, including delusional (OR = 2.07, 95% CI =1.38 to 
4.08), weight concerns (OR = 2.26, 95% CI = 1.17 to 4.36), and muscle dysmorphia concerns 
(OR = 5.12, 95% CI = 2.37 to 9.21) were at heightened risk for suicide attempts (Phillips et 
al, 2005). Lifetime functioning impairment due to BDD was found to be an independent 
predictor of both suicide attempts BDD (OR = 1.59, 95% CI = 1.15 to 2.19) and suicidal 
ideation in BDD (OR = 1.48, 95% CI = 1.14 to 1.91), whilst controlling for several factors 
(including comorbidities) using multivariate regression analyses (Phillips et al., 2005).  
3.4.2. Comparison of BDD and OCD 
 We identified five studies, which examined the effects of BDD and OCD on 
suicidality, but only two of these focused on comorbid BDD and OCD (Conceicao Costa et 
al., 2012; Frare et al., 2004). These two studies demonstrated that individuals with comorbid 
BDD and OCD had an increased risk for suicidality over and above OCD (suicidal ideation: 
pooled OR = 1.87, 95% CI = 1.15 to 2.60- I
2
 = 0%, p = 0.82; suicide attempts: OR = 2.78, 
95% CI = 1.66 to 4.65). Studies comparing the levels of suicidality between two distinct 
groups of OCD and BDD patients showed that suicidal ideation was significantly higher in 
BDD groups compared to OCD groups (pooled OR = 2.15, 95% CI = 1.02 to 3.28, I
2
 = 0%, p 
= 0.73) but no difference was observed in the rates of suicide attempts (pooled OR = 0.72, 
95% CI = 0.35 to 1.08, I
2
 = 0%, p = 0.45) (Phillips 2008; Phillips et al., 2007b; Weingarden et 
al., 2016).  
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3.4.3. Other psychiatric comorbidities 
 In addition to OCD, Phillips and co-workers (2005) showed that a range of comorbid 
psychiatric diagnoses were likely to be implicated in the underlying pathways to suicidality in 
BDD, such as, depressive disorders, eating disorders (i.e., anorexia nervosa or weight 
concerns), substance use disorders, posttraumatic stress disorder and personality disorders.  
Among these, comorbid major depression was found to be the strongest predictor of suicidal 
ideation in BDD (OR = 3.02, 95% CI = 1.30 to 6.99), whereas comorbid posttraumatic stress 
disorder (OR = 6.44, 95% CI = 1.54 to 26.93), and substance use disorders (OR = 3.07, 95% 
CI = 1.29 to 7.29), were the strongest predictors of suicide attempts in BDD.  Two additional 
studies reported substantially increased risk for suicide attempts in BDD in the presence of 
comorbid anorexia nervosa (OR = 6.67, 95% CI = 1.63 to 27.27) (Grant et al., 2002) and 
substance use disorders (OR = 2.67, 95% CI = 1.35 to 5.30) (Grant et al., 2005).  
3.4.4. Socio-demographic factors 
Two studies, including three independent samples (Bjornsson et al., 2013; Phillips et 
al., 2005), consistently found that BDD was associated with a 2.4-fold increase in suicide 
attempts (pooled OR = 2.36, 95% CI = 1.24 to 3.48, I
2
 = 0%, p = 0.84), if the onset of BDD 
symptoms occurred in childhood or adolescence as opposed to adulthood. However, no such 
differences were found with respect to suicidal ideation (pooled OR = 1.28, 95% CI = 0.69 to 
1.86, I
2
 = 0%, p = 0.66).  Phillips et al. (2005) found no differences for other demographics, 
such as, gender (OR = 0.98, 95% CI = 0.40 to 2.01) or marital status (OR = 1.09, 95% CI = 
0.73 to 1.20) between BDD individuals who experienced suicidality and those who did not 
experience suicidality.  
4. Discussion 
4.1. Summary of main findings 
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The first aim of this systematic review and meta-analysis was to investigate the 
associations between BDD and suicidal thoughts, attempts and deaths. Our findings 
confirmed that suicidality in BDD is a substantial concern that has not received sufficient 
research attention. Individuals diagnosed with BDD were four times more likely to experience 
suicidal ideation and 2.6 times more likely to engage in suicide attempts compared to 
individuals without BDD. These estimates are at least as high as those found in other anxiety 
disorders (OR = 2.89 95% CI = 2.09 to 4.00 for suicidal ideation and OR = 2.47, 95% CI = 
1.96 to 3.15 for suicide attempts; Kanwar et al., 2013) and comparable with severe psychiatric 
morbidities such as PTSD and major depression (ORs ranging from 4.8 to 5.7 for suicide 
attempts without controlling for other psychiatric comorbidities and 2.0 to 2.3 controlling for 
comorbidities) (Nock et al., 2010). 
With regard to suicide deaths, the Centers for Disease Control and Prevention reported 
a suicide death rate of 12.6% per 100.000 citizens in the USA (CDC, 2014). In this review, 
we only found one longitudinal study which reported that two out of 185 individuals with 
BDD died by suicide in a period of one year (Phillips & Menard, 2006). However, this study 
utilized a very small number of participants and had a brief follow-up period. Its direct 
comparison therefore with large national studies with extensive follow-up periods or 
psychological autopsy studies is not legitimate. Indeed, there is evidence that short-term 
longitudinal studies in other high risk populations such as schizophrenia and major depression 
found similar findings. A suicide death rate of 2.2% has been reported for patients with 
schizophrenia within a year (Limosin, Loze, Phillipe, Casadebaig, & Rouillon (2007), and 1% 
for patients with major depression within a 18 month-period (Sokero, Melartin, Rytsala, 
Leskela, Lestela-Mielonen, & Isometsa, 2005).  
In order to investigate suicidality in people experiencing BDD it is, perhaps, necessary 
to take a mixed methods approach given that it is difficult to detect BDD, and that death by 
suicide is rare. For example, an inclusive diagnostic approach to BDD could be taken, with 
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qualitative and quantitative techniques used to explore distal and proximal risk factors for 
suicidal thoughts and attempts. A novel way forward in this endeavor would be to examine 
not only "risk factors" for suicidality but also the factors which have allowed people with 
BDD to become resilient to suicidal thoughts and behaviors (Johnson et al., 2010). 
Furthermore, the application of the Integrated Motivational Volitional Model of Suicide 
(O'Connor, 2011) to understanding transitions from suicidal thoughts and plans to suicidal 
acts seems particularly germane to links experiencing BDD and the development of suicidal 
thoughts and acts. 
The second aim of this meta-analysis was to investigate the mechanisms underlying 
the relationship between BDD and suicidality with a focus on specific characteristics of BDD 
related to body image and appearance, co-morbid mental illnesses, and other clinical, 
psychological or demographic factors including social isolation or withdrawal. No evidence 
was available in the literature regarding the mechanisms underlying suicidality in BDD, with 
the exception of only one study that examined the relationship between BDD and the acquired 
capability for suicide by following the interpersonal-psychological theory of suicide (Witte et 
al., 2012). This study suggested that PTSD, major depressive disorder, lifetime work 
impairment owning to BDD and lifetime BDD-related restrictive food intake were among the 
key variables accounting for suicidality in BDD patients. This finding is in accord with other 
studies showing that the risk of suicidality is amplified by an increase in the number of mental 
illnesses experienced (Arsenault-Lapierre et al., 2004; Nock, Hang, Sampson, Kessler, 2010).  
It was notable that no study to date sought to examine mediational pathways in which 
adverse experiences, negative perceptions and unpleasant emotions arising from having BDD 
led to suicidal thoughts and acts both directly, and also indirectly via increased social anxiety 
and social withdrawal. These sort of pathways are postulated by models of suicidal thoughts 
and behaviors which can include the influence of diagnosis specific factors, including co-
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morbid illnesses, such as depression (Johnson et al., 2008; O'Connor & Nock, 2014; Van 
Orden et al., 2010).   
The third aim of this meta-analysis was to determine the extent to which a co-morbid 
presentation of OCD and BDD increased the probability of suicidality compared to either 
OCD or BDD alone. It was found that BDD amplified suicidality above the effects of OCD. 
That said, this finding was based on only two papers which tempers conclusions (Conceicao 
Costa et al., 2012; Frare et al., 2004).  
 
4.2. Key research inferences and future directions 
 Two key research inferences can be drawn from this systematic review and meta-
analysis. First, evidence was obtained that BDD groups exhibited significantly higher levels 
of suicidality compared to other psychiatric groups that have been established as at high-risk 
for suicidal thoughts and acts in the literature (Kosto, Lerman, & Attia, 2014; Novick, Swartz, 
& Frank, 2010). In particular, the majority of the control groups recruited in the studies 
included in this meta-analysis comprised individuals diagnosed with other severe mental 
illnesses (i.e., eating disorders, OCD, bipolar disorder) (Grant et al., 2001; Grant et al., 2002; 
Frare et al., 2004; Zimmerman et al., 1998). Despite this, suicidality rates in BDD groups 
exceeded suicidality rates in by 2.6 times compared to clinical controls and almost 6 times 
compared to non-clinical control. Taken together, these findings indicate that the levels of 
suicidality in BDD were worryingly high and that there is a need to produce higher-quality 
evidence to understand the mechanisms underlying BDD. With a clearer understanding of 
these underlying mechanisms it is then possible to develop psychological interventions which 
can ameliorate suicidal thoughts and behaviors in people with BDD (Tarrier et al., 2013).  
Second, initial evidence was obtained that a BDD diagnosis per se or specific BDD 
symptoms, including distorted body image concerns and functional impairments related to 
BDD, were strong predictors of suicidality. This finding is consistent with the evidence 
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showing that BDD is associated with high levels of depression, psychological distress and 
disability (Veale & Bewley, 2015). However, the degree to which BDD-specific factors lead 
to suicidality without the synergy of psychological and comorbidity factors is currently 
uncertain. This uncertainty derives from the lack of investigations examining pathways to 
suicidality which include hypothesized mediators (e.g., defeat, entrapment, hopelessness) and 
moderators (e.g., specific symptoms of BDD such as body image concerns, and symptoms of 
comorbid mental illnesses, such as depression). Clearly, it is important to further develop 
contemporary models of suicidal thoughts, feelings, and acts so that they apply to people who 
experience BDD. Three such models have identified perceptions of defeat, entrapment and 
hopelessness as being important in the pathways to suicidality across people experiencing a 
range of mental illnesses (Johnson et al., 2010; O'Connor & Nock, 2014; Tarrier et al., 2013; 
Williams, 1997). It will be important for future work to examine the roles of defeat and 
entrapment in relation to suicidality in BDD in addition to examining the impact of 
psychosocial factors, such as social isolation, social withdrawal and feelings of being a 
burden (Joiner et al., 2009). 
 
4.3. Strengths and limitations  
 This study has a number of strengths. First, it is the first systematic review to provide 
a comprehensive synthesis of the association between BDD and suicidality. Second, this 
review was performed and reported according to PRISMA guidance (e.g., Liberati et al., 
2009). Third, the literature search criteria were designed to be comprehensive and the 
eligibility criteria were broad to ensure that we incorporated all the evidence in the area.  
Fourth, two independent researchers were involved in all data screening and extraction, and 
reliability tests were performed, which indicated high levels of inter-rater agreement. 
 This review also has important limitations. The number of studies included in this 
review was modest and comprised heterogeneous populations and outcomes (i.e., different 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
   17 
 
forms of suicidality were assessed with a wide range of tools). We endeavored to account for 
the large heterogeneity by applying random effect models to adjust for between-study 
variations. However, we only explored the impact of basic sources of heterogeneity (e.g., 
different types of suicidality), because multiple subgroup analyses inflate the probability of 
finding false-positive results (Ioannidis, Patsopoulos, & Rothstein, 2008).  
 There is an argument that meta-analysis is inappropriate in the context of high levels 
of clinical, methodological and statistical heterogeneity, and the data may be more suited to a 
narrative synthesis (Ioannidis, Patsopoulos, & Rothstein, 2008). However, such syntheses are 
difficult to interpret. We adopted meta-analysis to allow us to compare results across studies, 
to examine the consistency of effects, and to explore variables that might account for 
inconsistency (Kontopantelis, Springate, Reeves, 2013).  
 Although the assessment of the methodological quality of the studies was not 
comprehensive, the selected criteria reflect all the key quality aspects of observational studies. 
However, the design of the included studies was mostly cross-sectional, which imposes limits 
on our ability to establish causal links between suicidality and BDD and the mechanisms that 
underpin these links.  
 Finally, in this study we combined data derived from psychiatric patients and those 
from the general population. This, potentially, could have inflated the rates of suicidality, 
since people diagnosed with mental illnesses tend to engage more often in suicide behaviors 
compared to healthy controls (e.g., Harris & Barraclough, 1997). In addition, the sample sizes 
of the patient population combined in this review were significantly smaller than those 
coming from the general community.      
4.4. Clinical implications and conclusions 
These findings indicate that suicidality could be a major concern among people 
presenting with BDD symptoms in clinical settings. At present, the lack of awareness about 
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the risk for suicidality in BDD suggests that these patients might not be appropriately assessed 
for suicide risk. Patients that should be primarily diagnosed with BDD go either misdiagnosed 
as having depression or undiagnosed (Conroy et al., 2008; Veale, Akyuz, & Hodsoll, 2015), 
which leads to an underestimation of suicide risk in BDD. Until now, no efforts have been 
made to therapeutically target suicidality in those with BDD. For instance, protocols of 
psychological therapies, which aim to treat BDD, often exclude patients who are actively 
suicidal (Wilhelm et al., 2011). Although, it is understandable that people with BDD, who 
also experience suicidality, are a particularly challenging population, it is very important not 
to exclude patients with the greatest need for interventions from accessing them. 
 This is the first systematic review and meta-analysis of the association between 
suicidality and BDD. Although the patterns within this association are complex, BDD was 
strongly associated with suicidality.  
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Fig. 1. PRISMA 2009 flow diagram for the entire review. 
 
  
Abstracts from 238 records were 
screened for eligibility  
 
 
51 records were eligible for full-text 
screening  
 
14 records excluded following reading the full-text: 
 
 10 reported no relevant data on suicidality and 
OCD 
 2 were non-empirical papers 
 2 were literature reviews 
 
 
 
Overall, 37 studies included in the review 
including 20 independent samples. 
274 records excluded 
following reading of title 
and abstract 
Sc
re
en
in
g 
El
ig
ib
ili
ty
 
In
cl
u
d
e
d
 
Records identified through database 
searching (n =325) 
 
 Duplicates removed (n =87) 
 
 
Id
e
n
ti
fi
ca
ti
o
n
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
   29 
 
 
 
 
Fig. 2. Forest plot of the main analysis of the association between suicidality and BDD. Note: 
Meta- analysis of individual studies and pooled effects. Random effects model used. 95% CI 
= 95% confidence intervals; ES= Odds ratio.  
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Fig. 3. Forest plot of the analysis of the association between different modes of suicidality 
and BDD. Note: Meta- analysis of individual studies and pooled effects. Random effects 
model used. 95% CI = 95% confidence intervals; ES= Odds ratio.  
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Fig. 4. Forest plot of the subgroup analysis of the association between BDD and suicidality 
across studies based on clinical populations and community surveys. Note: Meta- analysis of 
individual studies and pooled effects. Random effects model used. 95% CI = 95% confidence 
intervals; ES= Odds ratio.  
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Fig. 5. Funnel plot for studies examining the link between BDD and suicidality. Publication 
bias funnel plot showing standard error by the Odds ratios for the 11 studies which examined 
the association between suicidality and BDD. Egger’s regression intercept = -0.58 (SE = 
1.78), p = 0.312.  
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Table 1 
Characteristics of the studies included in the review 
Study Cou
ntry 
Stud
y 
Desi
gn 
Screening 
tool for 
BDD 
Screeni
ng tool 
for 
suicidal
ity 
Mode 
of 
suicid
ality 
Targe
t 
popul
ation 
Sa
mpl
e 
size 
N 
Me
n 
(%) 
Age 
(years) 
Repor
ted 
rates 
of 
Suici
dality 
Incl
uded 
in 
meta
-
anal
ysis 
 
Altam
ura et 
al., 
2001 
Italy Cros
s-
secti
onal 
A 
structured 
interview 
for DSM-
IV 
(SCID-I) 
and the 
Yale-
Brown 
Obsessive
-
Compulsi
ve Scale 
adapted 
for BDD 
(BDD-Y-
BOCS)  
A 
structur
ed 
intervie
w for 
DSM-
IV 
(SCID-
I) 
Suici
dal 
ideati
on 
 
BDD 
 
478 
 
24.7
% 
BDD = 
28.5 (SD 
= 2.3)    
sBDD = 
25.8 (SD 
= 9.0) 
Control = 
34.2 (SD 
= 12.7) 
+ + 
Albert
ini & 
Phillip
s, 
1999 
USA Cros
s-
secti
onal 
A semi-
structured 
interview 
for DSM-
IV 
(SCID-I), 
the BDD 
Data 
Form and 
the Yale-
Brown 
Obsessive
-
Compulsi
ve Scale 
adapted 
for BDD 
(BDD-Y-
BOCS) 
The 
BDD 
Form 
(Unpub
lished 
Scale) 
Lifeti
me 
suicid
al 
ideati
on & 
lifeti
me 
suicid
e 
attem
pts 
BDD 33 9 % 14.9 (SD 
= 2.2) 
+ - 
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Bjorns
son et 
al., 
2013 
Icela
nd 
Cros
s-
secti
onal 
The Yale-
Brown 
Obsessive
-
Compulsi
ve Scale 
adapted 
for BDD 
(BDD-Y-
BOCS), 
the 
Psychiatri
c Status 
Rating 
Scale for 
Body 
Dysmorph
ic 
Disorder 
(BDD-
PSR), the 
Body 
Dysmorph
ic 
Disorder 
Examinati
on 
(BDDE)  
Suicida
lity 
items 
from 
the 
Hamilt
on 
Rating 
Scale 
for 
Depres
sion 
Suici
dal 
ideati
on, 
suicid
al 
ideati
on 
due to 
BDD, 
attem
pted 
suicid
e, 
attem
pted 
suicid
e due 
to 
BDD 
BDD Sa
mpl
e 1: 
184     
Sa
mpl
e 2: 
244 
Sa
mpl
e 1: 
33.1
5% 
Sa
mpl
e 2: 
46.7
% 
Sample 1: 
First 
diagnosed 
before 18: 
33.8 (SD = 
12.3) 
First 
diagnosed 
after 18: 
34.6 (SD = 
9.8)   
Sample 2: 
First 
diagnosed 
before 18: 
32.6 (SD = 
10.9) 
First 
diagnosed 
after 18: 
32.4 (SD = 
8) 
+ - 
Buhlm
ann et 
al., 
2010 
Ger
man
y 
Cros
s-
secti
onal 
A 
questionn
aire 
assessing 
DSM 
criteria 
for 
current 
BDD  
A 
questio
nnaire 
assessi
ng 
suicidal
ity- No 
more 
informa
tion 
was 
provide
d 
Suici
dal 
ideati
on & 
suicid
e 
attem
pts 
BDD 251
0 
45.5
% 
46.9 (SD 
= 18.4) 
Range: 
14 - 93 
years old 
+ + 
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Conce
icao 
Costa 
et al., 
2012 
Braz
il 
Cros
s-
secti
onal 
The 
presence 
of BDD 
was 
defined in 
terms of 
lifetime 
prevalenc
e using 
SCID-I/P 
The 
followi
ng 
« yes » 
or 
« no » 
questio
ns were 
asked: 
(1) 
Have 
you 
ever 
thought 
about 
killing 
yoursel
f? (2) 
Have 
you 
ever 
made 
suicidal 
plans? 
and (3) 
Have 
you 
ever 
attempt
ed 
suicide
? 
Lifeti
me 
suicid
al 
ideati
on, 
plans 
and 
attem
pts 
 
OCD 901 42,7
 % 
34.4 (SD 
= 12.7) 
 
- + 
Conro
y et 
al., 
2008 
USA Cros
s-
secti
onal 
The Body 
Dysmorph
ic 
Disorder 
Questionn
aire 
(BDD-Q) 
and a 
Structured 
Clinical 
Interview 
for DSM- 
IV   
A brief 
version 
of the 
BDD 
Data 
Form 
(Unpub
lished 
Scale)  
Lifeti
me 
ideati
on 
and 
attem
pts 
BDD 100 31.2
% 
BDD: 
31.9 (SD 
= 11) 
NoBDD: 
40.9 (SD 
= 12.5)  
+ - 
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de 
Brito 
et al., 
2016 
Braz
il 
Cros
s-
secti
onal 
The Body 
Dysmorph
ic 
Disorder 
Examinati
on and the 
Clinical 
Assessme
nt for 
BDD 
 
n/r Lifeti
me 
suicid
al 
ideati
on & 
lifeti
me 
suicid
e 
attem
pts 
BDD 300 14.6
7% 
Abdomin
oplasty: 
38 (SD = 
11) 
Rhinopla
sty: 34 
(SD = 
12) 
Rhytidect
omy: 51 
(SD = 
10) 
+ + 
Dyl et 
al., 
2006 
USA Cros
s-
secti
onal 
The Body 
Dysmorph
ic 
Disorder 
Questionn
aire 
(BDDQ)  
The 
Suicide 
Probabi
lity 
Scale 
(SPS)  
Suici
dality 
BDD, 
Eatin
g 
Disor
ders 
208 37.5
% 
14.8 
years (SD 
= 1.4)  
- -? 
Frare 
et al., 
2004 
Italy Cros
s-
secti
onal 
A semi-
structured 
interview 
exploring 
the 
presence 
of DSM-
III-R 
diagnostic 
criteria 
for BDD 
Demog
raphic 
informa
tion 
based 
on the 
Adult 
Demog
raphic 
and 
Persona
l 
Invento
ry 
(ADPI) 
Suici
dal 
ideati
on 
BDD, 
OCD, 
BDD/
OCD 
137 61.9
% 
26.6  (SD 
= 7.4) 
+ + 
Grant 
et al., 
2001 
USA Cros
s-
secti
onal 
The Body 
Dysmorph
ic 
Disorder 
Questionn
aire 
(BDD-Q), 
a brief 
self-report 
screening 
measure 
Particip
ants 
were 
asked: 
How 
many 
suicide 
attempt
s have 
you 
made 
Suici
de 
attem
pts 
BDD 122 69.5
4% 
38.4 (SD 
= 10.1) 
+ + 
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that 
screens 
for BDD, 
a Semi-
structured 
Clinical 
Interview 
for DSM-
IV  
in your 
life? 
Grant 
et al., 
2002 
USA Cros
s-
secti
onal 
The Body 
Dysmorph
ic 
Disorder 
Questionn
aire 
(BDD- 
Q), a brief 
self-report 
measure 
that 
screens 
for body 
dysmorph
ic 
disorder, a 
Semi-
structured 
Clinical 
Interview 
for DSM-
IV 
Semi-
structur
ed 
diagnos
tic 
intervie
w 
(based 
on the 
Structu
red 
Clinical 
Intervie
w for 
DSM-
IV) to 
obtain 
number 
of 
suicide 
attempt
s  
 
Suici
de 
attem
pts 
Anore
xia 
nervo
sa 
41 0 % 26.7 
??(SD = 
9.4)  
+ + 
Kelly 
et al., 
2015 
USA Cros
s-
secti
onal 
The Body 
Dysmorph
ic 
Disorder 
Questionn
aire 
(BDD- 
Q), the 
Structured 
Clinical 
Interview 
for DSM-
IV Axis I 
Disorders 
- Patient 
Edition 
n/r Lifeti
me 
suicid
al 
ideati
on & 
lifeti
me 
suicid
e 
attem
pts  
BDD 100 88.3
% 
49.6 (SD 
= 13.7) 
+ + 
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(SCID- P) 
Perugi 
et al., 
1997 
Italy Cros
s-
secti
onal 
The 
Diagnosti
c 
Interview 
for 
Dysmorph
ophobia 
(DID), the 
Body 
Dysmorph
ic 
Symptom
s Scale 
(DSS), the 
Hopkins 
Symptom 
Checklist 
(HSCL 
90)  
The 
Body 
Dysmo
rphic 
Sympto
ms 
Scale 
(DSS) 
for 
suicidal 
ideatio
n 
Suici
dal 
ideati
on 
BDD 58 59 
% 
25 (SD = 
5.9) 
Range: 
16 - 45 
+ - 
Phillip
s et 
al., 
1998 
USA Cros
s-
secti
onal 
SCID-like 
instrumen
t based on 
the 
criteria of 
DSM-IV 
for BDD, 
BDD-Y-
BOCS 
n/r Suici
dal 
ideati
on & 
suicid
e 
attem
pts 
BDD 
and/or 
OCD 
139 53.2
4% 
BDD: 
32.4 (SD 
= 9.2) 
OCD: 
37.5 (SD 
= 11.1) 
OCD/BB
D: 33.1 
(SD = 
9.8) 
+ + 
Phillip
s et 
al., 
2005* 
USA Cros
s-
secti
onal 
The 
Structured 
Clinical 
Interview 
for DSM-
IV Axis I 
Disorders, 
Non-
Patient 
Edition 
The 
BDD 
Form 
(Unpub
lished 
Scale) 
Lifeti
me 
suicid
al 
ideati
on, 
lifeti
me 
suicid
e 
BDD 200 31.5
% 
32.6 (SD 
= 12.1) 
+ + 
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(SCID- 
NP), the 
Yale-
Brown 
Obsessive
-
Compulsi
ve Scale 
adapted 
for BDD 
(BDD-Y-
BOCS) 
attem
pts & 
compl
eted 
suicid
es 
Rief et 
al., 
2006 
Ger
man
y 
Cros
s-
secti
onal 
 A 
questionn
aire 
assessing 
DSM-
criteria 
for 
current 
BDD, a 
questionn
aire 
assessing 
clinical 
characteri
stics 
related to 
BDD 
symptoms
, the 
Screening 
for 
Somatofor
m 
Symptom
s (state 
version; 
SOMS-7) 
n/r Suici
dal 
ideati
on 
and 
suicid
e 
attem
pts 
due to 
appea
rance 
conce
rns 
BDD 255
2 
47.9
% 
47.6 (SD 
= 18) 
+ + 
Schieb
er et 
al., 
2015 
Ger
man
y 
Cros
s-
secti
onal 
A 
questionn
aire 
assessing 
DSM-
criteria 
for 
current 
BDD 
(based on 
An 
item 
from 
the 
Patient 
Health 
Questio
nnaire 
(PHQ-9 
Suici
dal 
ideati
on 
BDD 212
9 
46 
% 
45.3 (SD 
= 13) 
- + 
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both 
DSM-IV 
and DSM-
V criteria) 
Veale 
et al., 
1996 
UK Cros
s-
secti
onal 
The Body 
Dysmorph
ic 
Disorder 
Examinati
on 
(BDDE), 
the Yale-
Brown 
Obsessive
-
Compulsi
ve Scale 
adapted 
for BDD 
(BDD-Y-
BOCS) 
n/r Suici
de 
attem
pts 
BDD 50 48 
% 
32.6 
Range: 
19 - 58 
+ - 
Weing
arden 
et al., 
2016 
USA Cros
s-
secti
onal 
The Body 
Dysmorph
ic 
Disorder 
Questionn
aire 
(BDD- 
Q), the 
self-report 
BDD Y-
BOCS 
Suicide 
behavio
rs 
questio
nnaire 
– 
revised 
(SBQ-
R) 
Suici
dality 
BDD, 
OCD
D 
361 8% 30.22 
(SD = 
10.86) 
- + 
Zimm
erman 
& 
Mattia
, 1998 
USA Cros
s-
secti
onal 
The 
Structured 
Clinical 
Inter- 
view for 
DSM-IV 
(SCID) 
n/r Lifeti
me 
suicid
e 
attem
pts 
BDD 500 37.4
% 
39.6 (SD 
= 13.1) 
+ + 
Note. BDD = Body Dysmorphic Disorder, sBDD = subclinical Body Dysmorphic Disorder, 
DSM = Diagnostic and Statistical Manual of Mental Disorders, SCID = Structured Clinical 
Interview for DSM disorders, SD = standard deviation, n/r = not reported, + = Yes - = No.  
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* This is the primary study from which the majority of data were extracted. However, we also 
extracted relevant data from additional studies which used the same cohort of participants; 
details of these studies are included in Appendix 1
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Table 2 
Quality appraisal of the studies included in the review. 
Study  Study 
design 
Response 
rates at 
baseline 
Response 
rates at 
follow-up 
BDD 
tool 
reliable 
Suicidality 
tool 
reliable ? 
Confounding 
factors 
controlled? 
Total 
quality 
score 
 Altamura et 
al., 2001 
0 1 n/a 1 1 0 3 
Albertini & 
Phillips, 
1999 
0 1 n/a 1 1 0 3 
Bjornsson et 
al., 2013 
0 1 n/a 1 1 0 3 
Buhlmann et 
al., 2010 
0 1 n/a 1 1 0 3 
Conceicao 
Costa et al., 
2012 
0 1 n/a 1 1 1 4 
Conroy et 
al., 2008 
0 1 n/a 1 1 0 3 
de Brito et 
al., 2016 
0 1 n/a 1 0 0 2 
Dyl et al., 
2006  
0 1 n/a 1 1 0 3 
Frare et al., 0 1 n/a 1 1 0 3 
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2004 
Grant et al., 
2001 
0 1 n/a 1 1 0 3 
Kelly et al.,  
2015 
0 1 n/a 1 0 0 2 
Grant et al., 
2002 
0 1 n/a 1 1 0 3 
Perugi et al., 
1997 
0 1 n/a 1 1 0 3 
Phillips et 
al., 1998 
0 1 n/a 1 0 0 2 
Phillips et 
al., 2005 
0 1 n/a 1 1 0 3 
Rief et al., 
2006 
0 0 n/a 1 0 0 1 
Schieber et 
al., 2015 
0 0 n/a 1 1 0 2 
Veale et al., 
1996 
0 1 n/a 1 0 0 2 
Weingarden 
et al., 2016 
0 1 n/a 1 1 0 3 
Zimmerman 0 1 n/a 1 0 0 2 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 3 
& Mattia, 
1998 
Note. n/a = not applicable. 
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Highlights  
 The association between a diagnosis of BDD and suicidality was 
examined    
 The meta-analysis confirmed that suicidality in BDD is an 
important concern 
 BDD is more strongly linked to suicidality than other related 
illnesses including OCD and Anorexia nervosa 
 There is lack of evidence about the psychological mechanisms of 
suicidality in BDD 
